Effect of One-Week Salt Restriction on Blood Pressure Variability in Hypertensive Patients with Type 2 Diabetes
Overview
Authors
Affiliations
Background: Increased short-term blood pressure (BP) variability on 24-hour ambulatory BP monitoring (ABPM) is known to be a risk factor for cardiovascular events. However, very few studies have evaluated the effect of salt restriction on BP variability particularly in hypertensive patients with type 2 diabetes. This study aimed to investigate the effect of salt restriction on systolic BP (SBP) variability.
Methods And Results: 10 hypertensive patients with type 2 diabetes and not receiving antihypertensive agents were enrolled in the study. After admission, all patients received a salt-restricted diet and appropriate anti-diabetic treatments and were followed up for 7 consecutive days using ABPM. After the 7-day treatment, the median [interquartile range (IQR)] coefficient of variation (CV) for diurnal SBP variability changed from day 1 to day 7-13.0 [10.8 to 16.8] % to 13.3 [9.1 to 18.9] % (P = 0.959)--and the median [IQR] change between days 1 and 7 was -0.3 [-3.2 to 2.9] %. In addition, CV for BP variability and circadian rhythm of BP varied greatly on a day-by-day basis for 7 days, compared to mean BP values. Interestingly, increased SBP variability was associated with greater day-by-day changes in circadian rhythm of BP.
Conclusions: Salt restriction during 7-day hospitalization led to a -0.3 [-3.2 to 2.9] (median [IQR]) % change from baseline in CV for diurnal SBP variability in 10 hypertensive patients with type 2 diabetes not receiving antihypertensive agents.
Trial Registration: UMIN Clinical Trials Registry UMIN000016243.
Gholizadeh-Moghaddam M, Shahdadian F, Shirani F, Hadi A, Clark C, Rouhani M Food Sci Nutr. 2023; 11(4):1622-1633.
PMID: 37051341 PMC: 10084959. DOI: 10.1002/fsn3.3212.
Zhou T, Schutten M, Kroon A, Henry R, Houben A, van der Kallen C J Am Heart Assoc. 2022; 12(1):e026578.
PMID: 36565181 PMC: 9973596. DOI: 10.1161/JAHA.122.026578.
Migdal K, Babcock M, Robinson A, Watso J, Wenner M, Stocker S Am J Hypertens. 2020; 33(5):422-429.
PMID: 32006422 PMC: 7188796. DOI: 10.1093/ajh/hpaa014.
Chen A, Moran J, Libianto R, Baqar S, OCallaghan C, MacIsaac R J Hum Hypertens. 2019; 34(2):143-150.
PMID: 31501493 DOI: 10.1038/s41371-019-0238-3.
Yan Y, Wang J, Chaudhry M, Nie Y, Sun S, Carmon J Int J Mol Sci. 2019; 20(14).
PMID: 31315267 PMC: 6678942. DOI: 10.3390/ijms20143495.